• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WALLFLEX ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WALLFLEX ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL Back to Search Results
Device Problem Migration (4003)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/18/2022
Event Type  Injury  
Manufacturer Narrative
The complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.(b)(4).The wallflex esophageal stent has not been received for analysis.A labeling review was performed and, from the information available, this device was used per the instructions for use (ifu) / product label.Stent migration is a known potential adverse effect associated with esophageal stent placement and is noted within the instructions for use (ifu) / product label.Therefore, the investigation concludes that the most probable cause of the event is a known inherent risk of the device.
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2022 that a wallflex esophageal stent was implanted in the mid esophagus to treat a tracheoesophageal fistula during a procedure performed on an unknown date.On (b)(6) 2022, post stent placement, the wallflex esophageal stent migrated.It was noted that it was not a complete migration.The stent was removed from the patient and an agile esophageal stent was implanted and the procedure was completed.There were no patient complications reported as a result of this event.
 
Manufacturer Narrative
Blocks b5 has been updated with additional information received on june 10, 2022.Block d4, h4: the complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.Block h6: medical device problem code a010402 captures the reportable event of stent migration.Impact code f23 captures the additional intervention of stent removal and replacement of the migrated stent.Block h10: the wallflex esophageal stent has not been received for analysis.A labeling review was performed and, from the information available, this device was used per the instructions for use (ifu) / product label.Stent migration is a known potential adverse effect associated with esophageal stent placement and is noted within the instructions for use (ifu) / product label.Therefore, the investigation concludes that the most probable cause of the event is a known inherent risk of the device.
 
Event Description
It was reported to boston scientific corporation on may 18, 2022 that a wallflex esophageal stent was implanted in the mid esophagus to treat a tracheoesophageal fistula during a procedure performed on an unknown date.On may 18, 2022, post stent placement, the wallflex esophageal stent migrated.It was noted that it was not a complete migration.The stent was removed from the patient and an agile esophageal stent was implanted and the procedure was completed.There were no patient complications reported as a result of this event.Additional information received on june 10, 2022.The complainant reported that the stent migrated about an inch in the center of the esophagus.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLFLEX ESOPHAGEAL
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key14655316
MDR Text Key293726686
Report Number3005099803-2022-03135
Device Sequence Number1
Product Code ESW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K091510
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/10/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/10/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-